Enzyme replacement for severe pancreatitis with weight loss
Part of Digestive system clinical trials.
This trial tests whether pancreatic enzyme replacement therapy (PERT) helps patients with severe acute pancreatitis who have significant pancreatic damage and weight loss. The treatment may improve digestion and help regain weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with acute pancreatitis based on standard criteria.
- At least half of your pancreas has died (necrosis) due to this episode.
- You have lost more than 10% of your body weight since the pancreatitis began.
- You are between 18 and 60 years old.
- You have not had chronic pancreatitis, recurrent acute pancreatitis, or pancreatic cancer.
- You are not pregnant or breastfeeding, and you can give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a pancreatic enzyme replacement therapy (PERT) can help people who still have digestive problems after a recent episode of acute pancreatitis. The goal is to see if it improves symptoms like stomach pain, bloating, or diarrhea.
This trial tests if a pancreatic enzyme replacement therapy (PERT) helps weight loss caused by tumors in the head of the pancreas. It may improve nutrition for people with advanced pancreatic cancer.
This trial tests if taking pancreatic enzyme pills can help people who have lost weight after a severe first-time pancreas attack with more than half of the organ damaged. It aims to see if the pills improve nutrition and recovery.
This trial tests a new blood test to measure how well your pancreas works. It may help people with chronic pancreatitis understand their condition and quality of life.
This trial tests whether enzymes from microbes work as well as enzymes from pigs to help people with chronic pancreatitis digest food better. It aims to find a treatment that reduces symptoms like pain and poor digestion.
This study tests whether a medication called RELiZORB can help adults with moderate to severe acute pancreatitis (sudden, severe pancreas inflammation) tolerate nutrition delivered through a feeding tube. If your body is struggling to accept enough nutrition during acute pancreatitis, this trial may help you receive adequate nutrition while you recover.
Hear when a new Nutrition Assessment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.